Alberts P[au] - Search Results

Year	Number of Results
1970	1
1976	1
1979	1
1981	1
1982	6
1983	1
1984	1
1985	4
1986	1
1987	1
1988	1
1989	2
1990	1
1992	1
1993	1
1995	2
1998	1
1999	2
2000	4
2001	2
2002	5
2003	5
2004	1
2005	4
2006	3
2007	1
2008	1
2009	3
2010	2
2011	4
2012	5
2013	2
2014	1
2015	1
2016	1
2018	4
2019	3
2020	7
2021	1
2022	0

1

The advent of oncolytic virotherapy in oncology: The Rigvir® story.

Alberts P, Tilgase A, Rasa A, Bandere K, Venskus D. Alberts P, et al. Eur J Pharmacol. 2018 Oct 15;837:117-126. doi: 10.1016/j.ejphar.2018.08.042. Epub 2018 Sep 1. Eur J Pharmacol. 2018. PMID: 30179611 Free article. Review.

2

Effect of oncolytic ECHO-7 virus strain Rigvir on uveal melanoma cell lines.

Tilgase A, Grīne L, Blāķe I, Borodušķis M, Rasa A, Alberts P. Tilgase A, et al. Among authors: alberts p. BMC Res Notes. 2020 Apr 16;13(1):222. doi: 10.1186/s13104-020-05068-4. BMC Res Notes. 2020. PMID: 32299493 Free PMC article.

3

Premenstrual syndrome.

Alberts PS. Alberts PS. JOGN Nurs. 1984 Nov-Dec;13(6):413. doi: 10.1111/j.1552-6909.1984.tb02195.x. JOGN Nurs. 1984. PMID: 6569216 No abstract available.

4

Clostridial neurotoxin-insensitive vesicular SNAREs in exocytosis and endocytosis.

Martinez-Arca S, Alberts P, Galli T. Martinez-Arca S, et al. Among authors: alberts p. Biol Cell. 2000 Sep;92(6):449-53. doi: 10.1016/s0248-4900(00)01096-0. Biol Cell. 2000. PMID: 11132707 Review. No abstract available.

5

4-Week repeated dose rat GLP toxicity study of oncolytic ECHO-7 virus Rigvir administered intramuscularly with a 4-week recovery period.

Piwoni K, Jaeckel G, Rasa A, Alberts P. Piwoni K, et al. Among authors: alberts p. Toxicol Rep. 2021 Jan 19;8:230-238. doi: 10.1016/j.toxrep.2021.01.009. eCollection 2021. Toxicol Rep. 2021. PMID: 33537211 Free PMC article.

6

Effect of pharmaceutical interventions targeting thromboxane receptors and thromboxane synthase in cardiovascular and renal diseases.

Sakariassen KS, Alberts P, Fontana P, Mann J, Bounameaux H, Sorensen AS. Sakariassen KS, et al. Among authors: alberts p. Future Cardiol. 2009 Sep;5(5):479-93. doi: 10.2217/fca.09.33. Future Cardiol. 2009. PMID: 19715412 Review.

7

Comment on McCarthy, C.; et al. Developing Picornaviruses for Cancer Therapy. Cancers 2019, 11, 685.

Alberts P. Alberts P. Cancers (Basel). 2020 Jul 3;12(7):1775. doi: 10.3390/cancers12071775. Cancers (Basel). 2020. PMID: 32635366 Free PMC article.

8

The cell outgrowth secretory endosome (COSE): a specialized compartment involved in neuronal morphogenesis.

Alberts P, Galli T. Alberts P, et al. Biol Cell. 2003 Oct;95(7):419-24. doi: 10.1016/s0248-4900(03)00074-1. Biol Cell. 2003. PMID: 14597259 Review.

9

Subtype classification of presynaptic alpha 2-adrenoceptors.

Alberts P. Alberts P. Gen Pharmacol. 1993 Jan;24(1):1-8. doi: 10.1016/0306-3623(93)90003-g. Gen Pharmacol. 1993. PMID: 8387042 Review.

10

Comment on: Malfitano, A.M. et al. "Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer" Cancers 2019, 11, 1532.

Alberts P. Alberts P. Cancers (Basel). 2020 Jan 22;12(2):263. doi: 10.3390/cancers12020263. Cancers (Basel). 2020. PMID: 31978984 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results